Metropolitan Life Insurance Company (MetLife)’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-745
| Closed | -$25K | – | 193 |
|
|
2024
Q1 | $25K | Hold |
745
| – | – | ﹤0.01% | 1747 |
|
|
2023
Q4 | $24.8K | Hold |
745
| – | – | ﹤0.01% | 1818 |
|
|
2023
Q3 | $23.4K | Sell |
745
-370
| -33% | -$11.6K | ﹤0.01% | 1814 |
|
|
2023
Q2 | $35.3K | Hold |
1,115
| – | – | ﹤0.01% | 1637 |
|
|
2023
Q1 | $36.8K | Hold |
1,115
| – | – | ﹤0.01% | 1558 |
|
|
2022
Q4 | $35.9K | Hold |
1,115
| – | – | ﹤0.01% | 1681 |
|
|
2022
Q3 | $39.8K | Buy |
1,115
+320
| +40% | +$13.3K | ﹤0.01% | 1607 |
|
|
2022
Q2 | $32.7K | Hold |
795
| – | – | ﹤0.01% | 1765 |
|
|
2022
Q1 | $46K | Sell |
795
-2,204
| -73% | -$121K | ﹤0.01% | 1647 |
|
|
2021
Q4 | $176K | Hold |
2,999
| – | – | ﹤0.01% | 2109 |
|
|
2021
Q3 | $182K | Hold |
2,999
| – | – | ﹤0.01% | 2152 |
|
|
2021
Q2 | $180K | Sell |
2,999
-883
| -23% | -$44.2K | ﹤0.01% | 2226 |
|
|
2021
Q1 | $183K | Sell |
3,882
-329
| -8% | -$13.5K | ﹤0.01% | 2080 |
|
|
2020
Q4 | $158K | Hold |
4,211
| – | – | ﹤0.01% | 2099 |
|
|
2020
Q3 | $138K | Hold |
4,211
| – | – | ﹤0.01% | 2027 |
|
|
2020
Q2 | $191K | Buy |
4,211
+951
| +29% | +$48.6K | ﹤0.01% | 1828 |
|
|
2020
Q1 | $149K | Hold |
3,260
| – | – | ﹤0.01% | 1773 |
|
|
2019
Q4 | $141K | Hold |
3,260
| – | – | ﹤0.01% | 2138 |
|
|
2019
Q3 | $118K | Hold |
3,260
| – | – | ﹤0.01% | 2209 |
|
|
2019
Q2 | $153K | Hold |
3,260
| – | – | ﹤0.01% | 2066 |
|
|
2019
Q1 | $115K | Hold |
3,260
| – | – | ﹤0.01% | 2244 |
|
|
2018
Q4 | $122K | Hold |
3,260
| – | – | ﹤0.01% | 2142 |
|
|
2018
Q3 | $111K | Buy |
+3,260
| New | +$95.4K | ﹤0.01% | 2392 |
|
|
2018
Q2 | – | Sell |
-2,871
| Closed | -$85.7K | – | 2451 |
|
|
2018
Q1 | $85.7K | Sell |
2,871
-433
| -13% | -$14.5K | ﹤0.01% | 2357 |
|
|
2017
Q4 | $106K | Sell |
3,304
-2,121
| -39% | -$68.3K | ﹤0.01% | 2277 |
|
|
2017
Q3 | $162K | Hold |
5,425
| – | – | ﹤0.01% | 2359 |
|
|
2017
Q2 | $126K | Hold |
5,425
| – | – | ﹤0.01% | 2490 |
|
|
2017
Q1 | $119K | Hold |
5,425
| – | – | ﹤0.01% | 2427 |
|
|
2016
Q4 | $122K | Hold |
5,425
| – | – | ﹤0.01% | 2509 |
|
|
2016
Q3 | $124K | Sell |
5,425
-4,917
| -48% | -$110K | ﹤0.01% | 2524 |
|
|
2016
Q2 | $221K | Hold |
10,342
| – | – | ﹤0.01% | 2254 |
|
|
2016
Q1 | $355K | Hold |
10,342
| – | – | ﹤0.01% | 1800 |
|
|
2015
Q4 | $284K | Hold |
10,342
| – | – | ﹤0.01% | 2004 |
|
|
2015
Q3 | $309K | Sell |
10,342
-351
| -3% | -$11.5K | ﹤0.01% | 1960 |
|
|
2015
Q2 | $450K | Buy |
+10,693
| New | +$505K | ﹤0.01% | 1823 |
|
Other funds holding ATEX
OCAM
HCL
SCM
QF
Metropolitan Life Insurance Company (MetLife)'s ATEX Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Anterix (ATEX) in Q2 2024, closing a stake of 745 shares — an estimated $25K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ATEX in Q2 2015 and held it in 35 quarters. The position peaked at $450K in Q2 2015. 114 funds tracked by Wall St. Rank hold ATEX as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Anterix position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 745 Anterix shares in Q2 2024, an estimated $25K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Anterix in Q2 2015 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Anterix position peaked at $450K in Q2 2015.
- 114 funds tracked by Wall St. Rank held Anterix as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.